Dynamic modulation of prohormone convertase 2 (PC2)-mediated precursor processing by 7B2 protein: preferential effect on glucagon synthesis.
The small neuroendocrine protein 7B2 is required for the production of active prohormone convertase 2 (PC2), an enzyme involved in the synthesis of peptide hormones, such as glucagon and proopiomelanocortin-derived α-melanocyte-stimulating hormone. However, whether 7B2 can dynamically modulate peptide production through regulation of PC2 activity remains unclear. Infection of the pancreatic alpha cell line α-TC6 with 7B2-encoding adenovirus efficiently increased production of glucagon, whereas siRNA-mediated knockdown of 7B2 significantly decreased stored glucagon. Furthermore, rescue of 7B2 expression in primary pituitary cultures prepared from 7B2 null mice restored melanocyte-stimulating hormone production, substantiating the role of 7B2 as a regulatory factor in peptide biosynthesis. In anterior pituitary and pancreatic beta cell lines, however, overexpression of 7B2 affected neither production nor secretion of peptides despite increased release of active PC2. In direct contrast, 7B2 overexpression decreased the secretion and increased the activity of PC2 within α-TC6 cells; the increased intracellular concentration of active PC2 within these cells may therefore account for the enhanced production of glucagon. In line with these findings, we found elevated circulating glucagon levels in 7B2-overexpressing cast/cast mice in vivo. Surprisingly, when proopiomelanocortin and proglucagon were co-expressed in either pituitary or pancreatic alpha cell lines, proglucagon processing was preferentially decreased when 7B2 was knocked down. Taken together, these results suggest that proglucagon cleavage has a greater dependence on PC2 activity than other precursors and moreover that 7B2-dependent routing of PC2 to secretory granules is cell line-specific. The manipulation of 7B2 could therefore represent an effective way to selectively regulate synthesis of certain PC2-dependent peptides.
Department of Anatomy and Neurobiology, University of Maryland School of Medicine, Baltimore, Maryland 21201.
Michael
M
Helwig
Research Center for Natural Human Defense System, Yonsei University College of Medicine, Seoul 120-752, Korea.
Sang-Nam
SN
Lee
Molecular Therapy Research Center, Sungkyunkwan University, Seoul 135-710, Korea.
Jae Ryoung
JR
Hwang
Department of Anatomy and Neurobiology, University of Maryland School of Medicine, Baltimore, Maryland 21201.
Akihiko
A
Ozawa
Department of Animal Science, University of California, Davis, California 95616-8521.
Juan F
JF
Medrano
Department of Anatomy and Neurobiology, University of Maryland School of Medicine, Baltimore, Maryland 21201. Electronic address: ilind001@umaryland.edu.
Iris
I
Lindberg
D000818:Animals; D002460:Cell Line; D005260:Female; D005934:Glucagon / Q000378:metabolism*; D007515:Islets of Langerhans / Q000378:metabolism; D008297:Male; D051379:Mice; D051859:Neuroendocrine Secretory Protein 7B2 / Q000378:metabolism*; D010179:Pancreas / Q000378:metabolism; D010455:Peptides / Q000737:chemistry; D010902:Pituitary Gland / Q000378:metabolism; D011333:Pro-Opiomelanocortin / Q000378:metabolism; D045706:Proprotein Convertase 2 / Q000378:metabolism*; D011499:Protein Processing, Post-Translational; D034622:RNA Interference
D051859:Neuroendocrine Secretory Protein 7B2; D010455:Peptides; D011333:Pro-Opiomelanocortin; D005934:Glucagon; D045706:Proprotein Convertase 2